Reversibility of acute demyelinating lesions in relapsing-remitting multiple sclerosis.
Khan
O A
OA
Department of Neurology, University of Maryland School of Medicine, Baltimore, USA.
Rothman
M I
MI
D000328:Adult; D001921:Brain / Q000473:pathology*; D003711:Demyelinating Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D012074:Remission Induction; D012720:Severity of Illness Index
D005938:Glucocorticoids; D008775:Methylprednisolone